Los Angeles Capital Management LLC Veru Inc. Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$4.35 - $15.85 $570,572 - $2.08 Million	-131,166 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$4.55 - $6.41 $5,551 - $7,820	-1,220 Reduced 0.92%	131,166 $634,000
Q4 2021 Feb 03, 2022	BUY	$5.89 - $9.73 $206,267 - $340,744	35,020 Added 35.97%	132,386 $780,000
Q3 2021 Nov 08, 2021	SELL	$6.78 - $9.89 $190,741 - $278,235	-28,133 Reduced 22.42%	97,366 $831,000
Q2 2021 Aug 05, 2021	BUY	$7.24 - $11.2 $908,612 - $1.41 Million	125,499 New	125,499 $1.01 Million

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $53.7M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.